United States Pharmaceutical Logistics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The united states pharmaceutical logistics market size is expected to grow from USD 75.96 billion in 2025 to USD 78.65 billion in 2026 and is forecast to reach USD 93.47 billion by 2031 at a 3.51% CAGR over 2026-2031. This report is Segmented by Service Type (Transportation, Warehousing & Storage, and More), by Mode of Operation (Cold-Chain Logistics, Non-Cold-Chain Logistics), by Product Type (Prescription Drugs, OTC Drugs, Biologics & Biosimilars, Veterinary Medicine, and More), and by Country (Northeast, Midwest, South, West). The Market Forecasts are Provided in Terms of Value (USD).

United States Pharmaceutical Logistics Market Trends and Insights

Ongoing mRNA-Vaccine Booster Programs Driving Nationwide ULT Capacity

Annual COVID-19 booster recommendations extend ultra-low-temperature (ULT) infrastructure from a pandemic response to a standing requirement. The Centers for Disease Control and Prevention advises yearly vaccination for everyone aged six months and older. Only 15% of United States pharmacies had freezers capable of -70 °C storage prior to 2020, so carriers now invest in dry-ice replenishment, redundant power, and trained crews to avoid excursions. Permanent ULT lanes lower marginal costs for emerging mRNA oncology and rare-disease therapies, encouraging manufacturers to collocate production with certified logistics hubs. Providers that secure guaranteed capacity at -70 °C enjoy pricing power and higher asset utilization, raising barriers for late entrants. The shift from surge shipments to predictable seasonal volumes also enables network planners to reposition containers and reduce empty miles.

Surge of Specialty and Mail-Order Pharmacies Boosting Parcel-Level Pharma Freight

Mail-order prescriptions reached 42% market share in 2024. CVS Caremark alone processes millions of patient-specific parcels every month through automated fulfillment centers. Instead of pallet shipments to wholesalers, manufacturers now tender small, high-value cartons that ride express networks with hour-by-hour monitoring. Specialty drugs represent 2% of prescriptions but half of spending; their temperature sensitivity and limited dispensing networks command premium freight rates. Reverse logistics for unused injectables and data loggers create backhaul opportunities yet add regulatory paperwork. Express carriers differentiate through late pickup windows, in-transit interventions, and integrated reimbursement data that satisfy payer audits

Truck-Driver Shortages and HOS Limits Constraining Time-Critical Road Capacity

The American Trucking Associations estimated a 78,000-driver shortfall in 2024 and warns of deficits exceeding 160,000 by 2031. Pharmaceutical lanes need hazmat certificates, temperature-controlled experience, and security clearances, shrinking the eligible pool even further. Hours-of-Service rules cap single-driver reach, so distributors rely on team driving or relay models that inflate costs. Wage offers rose 8-10% in 2025 but failed to offset retirements, leaving rural hospitals exposed to delayed replenishment. Some carriers pilot autonomous yard tractors and electric straight trucks, yet regulatory and infrastructure hurdles prevent near-term scale.

Other drivers and restraints analyzed in the detailed report include:

• Record Orphan-Drug Approvals Requiring Niche Temperature-Secure Lanes
• Decentralized Clinical Trials Creating Micro-Fulfillment Flows
• Escalating Warehouse Rents in Gateway Metros Compressing 3PL Margins

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Transportation services generated 71.07% of the United States pharmaceutical logistics market revenue in 2025, reflecting the central role of road and air capacity. Value-added services, although smaller, are projected to grow at a 5.24% CAGR through 2031 as manufacturers outsource serialization, kitting, and regulatory documentation. Road freight retains leadership because trucks provide door-to-door temperature control and security, but driver shortages lengthen lead times. Air freight remains indispensable for clinical supplies, shortage mitigation, and high-value biologics. Sea freight gains limited traction for non-urgent cargo as firms chase lower emissions, while rail remains niche.

Cardinal Health’s Fort Worth automated center ships 10,000 orders daily, illustrating how robotics lifts productivity across transportation, warehousing, and value-added tasks. Warehousing & Storage demand grows moderately because reshoring drives higher domestic inventories, and direct-to-patient models need forward-deployed stock. Providers blend pick-by-light, cold tunnels, and blockchain hand-offs to cut error rates. As execution expands beyond pallets to compliance paperwork, shippers increasingly award integrated contracts, deepening the competitive moat for full-service carriers.

Complete Report Scope:

• By Service Type
  • Transportation
    • Road Freight
    • Air Freight
    • Sea Freight
    • Rail Freight
  • Warehousing and Storage
  • Value-added Services and Others
• By Mode of Operation
  • Cold-Chain Logistics
  • Non-Cold-Chain Logistics
• By Product Type
  • Prescription Drugs
  • OTC Drugs
  • Biologics and Biosimilars
  • Vaccines and Blood Products
  • Clinical Trail Materials
  • Cell and Gene Therapies
  • Medical Devices and Diagnostics
  • Veterinary Medicine
  • Others
• By Region (United States)
  • Northeast
  • Midwest
  • South
  • West

List of Companies Covered in this Report:

• DHL Supply Chain & Global Forwarding
• FedEx
• UPS
• Cencora
• C.H. Robinson
• XPO Logistics
• Ryder System
• Penske Logistics
• Expeditors International
• SEKO Logistics
• LifeScience Logistics
• MD Logistics
• DSV
• Kuehne + Nagel
• Hub Group
• Nippon Express
• CEVA Logistics
• GXO Logistics
• KRC Logistics
• Langham Logistics
• Crown LSP Group

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support